Astera Labs (NASDAQ:ALAB) Stock Price Down 6.2% – Should You Sell?

Astera Labs, Inc. (NASDAQ:ALAB) shares traded down 6.2% on Tuesday . The stock traded as low as $278.00 and last traded at $278.5710. 687,281 shares traded hands during mid-day trading, a decline of 87% from the average daily volume of 5,318,744 shares. The stock had previously closed at $296.98.

Analyst Ratings Changes

A number of research analysts recently weighed in on ALAB shares. Roth Capital reaffirmed a “buy” rating and issued a $450.00 price target on shares of Astera Labs in a research note on Wednesday, August 5th. Needham & Company LLC upped their price objective on Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a research note on Wednesday, August 5th. UBS Group reissued a “neutral” rating and issued a $425.00 price target on shares of Astera Labs in a report on Wednesday, August 5th. Weiss Ratings restated a “hold (c)” rating on shares of Astera Labs in a research note on Tuesday, August 18th. Finally, Barclays increased their price objective on Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a research note on Monday, July 20th. One research analyst has rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and eight have assigned a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $340.53.

Astera Labs Trading Down 6.4%

The company has a market cap of $48.22 billion, a P/E ratio of 137.68 and a beta of 3.84. The company has a 50-day simple moving average of $339.53 and a 200 day simple moving average of $250.89.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company had revenue of $392.40 million for the quarter, compared to analysts’ expectations of $360.85 million. During the same period in the previous year, the firm earned $0.44 EPS. The firm’s revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities analysts forecast that Astera Labs, Inc. will post 2.7 EPS for the current fiscal year.

Insider Activity

In related news, CEO Jitendra Mohan sold 90,630 shares of the business’s stock in a transaction on Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the transaction, the chief executive officer directly owned 1,266,665 shares in the company, valued at approximately $431,109,432.75. The trade was a 6.68% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Jack R. Lazar sold 10,000 shares of the company’s stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the transaction, the director owned 75,688 shares of the company’s stock, valued at approximately $26,882,106.96. This represents a 11.67% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 419,244 shares of company stock valued at $163,135,169. Company insiders own 10.40% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

Institutional investors have recently bought and sold shares of the company. Keating Financial Advisory Services Inc. bought a new stake in shares of Astera Labs during the 2nd quarter valued at approximately $25,000. Archer Investment Corp purchased a new stake in Astera Labs during the second quarter worth $30,000. Transamerica Financial Advisors LLC purchased a new position in Astera Labs in the 2nd quarter worth approximately $35,000. Continuum Advisory LLC purchased a new position in Astera Labs during the 2nd quarter valued at about $37,000. Finally, Johnson Financial Group Inc. bought a new stake in shares of Astera Labs in the 2nd quarter worth $43,000. Institutional investors own 60.47% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.